Edwards Lifesciences Corporation (EW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Edwards Lifesciences Corp...

    NYSE: EW · Real-Time Price · USD
    80.90
    -0.06 (-0.07%)
    At close: Sep 05, 2025, 3:59 PM
    80.94
    0.05%
    After-hours: Sep 05, 2025, 05:06 PM EDT

    Edwards Lifesciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 5.44B 5.01B 5.38B 5.23B
    Cost of Revenue
    		 1.12B 1.04B 1.17B 1.23B
    Gross Profit
    		 4.32B 3.97B 4.22B 4.01B
    Operating Income
    		 1.38B 1.43B 1.7B 1.61B
    Interest Income
    		 120.3M 67.2M 35.5M 17.4M
    Pretax Income
    		 1.55B 1.37B 1.77B 1.7B
    Net Income
    		 4.17B 1.4B 1.52B 1.5B
    Selling & General & Admin
    		 1.79B 1.58B 1.57B 1.49B
    Research & Development
    		 1.05B 962.9M 945.2M 903.1M
    Other Expenses
    		 101.1M n/a n/a n/a
    Operating Expenses
    		 2.94B 2.55B 2.51B 2.4B
    Interest Expense
    		 19.8M 17.6M 26.2M 24.8M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 4.06B 3.58B 3.68B 3.62B
    Income Tax Expense
    		 152.1M 152.4M 245.5M 198.9M
    Shares Outstanding (Basic)
    		 597.7M 606.7M 619M 623.3M
    Shares Outstanding (Diluted)
    		 599.3M 609.4M 624.2M 631.2M
    EPS (Basic)
    		 6.98 2.31 2.46 2.41
    EPS (Diluted)
    		 6.97 2.30 2.44 2.38
    EBITDA
    		 1.72B 1.53B 1.96B 1.89B
    EBIT
    		 1.57B 1.39B 1.79B 1.73B
    Depreciation & Amortization
    		 155.2M 144.9M 166.8M 163.3M

    Add to Watchlist